nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A7—Sorafenib—liver cancer	0.177	0.311	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.177	0.311	CbGbCtD
Eplerenone—CYP3A5—Sorafenib—liver cancer	0.133	0.233	CbGbCtD
Eplerenone—CYP3A4—Sorafenib—liver cancer	0.0519	0.0908	CbGbCtD
Eplerenone—CYP3A4—Doxorubicin—liver cancer	0.0315	0.0551	CbGbCtD
Eplerenone—Proteinuria—Sorafenib—liver cancer	0.00412	0.0157	CcSEcCtD
Eplerenone—Protein urine present—Sorafenib—liver cancer	0.00406	0.0155	CcSEcCtD
Eplerenone—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.004	0.0153	CcSEcCtD
Eplerenone—Influenza like illness—Sorafenib—liver cancer	0.00351	0.0134	CcSEcCtD
Eplerenone—Gynaecomastia—Sorafenib—liver cancer	0.00324	0.0123	CcSEcCtD
Eplerenone—Kidney function abnormal—Epirubicin—liver cancer	0.00277	0.0105	CcSEcCtD
Eplerenone—Hyponatraemia—Sorafenib—liver cancer	0.00264	0.01	CcSEcCtD
Eplerenone—Kidney function abnormal—Doxorubicin—liver cancer	0.00256	0.00975	CcSEcCtD
Eplerenone—Dehydration—Sorafenib—liver cancer	0.00244	0.0093	CcSEcCtD
Eplerenone—Urine abnormality—Epirubicin—liver cancer	0.00241	0.0092	CcSEcCtD
Eplerenone—Hypokalaemia—Sorafenib—liver cancer	0.00239	0.00911	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00236	0.00901	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00232	0.00882	CcSEcCtD
Eplerenone—Urine analysis abnormal—Epirubicin—liver cancer	0.00227	0.00866	CcSEcCtD
Eplerenone—Urine abnormality—Doxorubicin—liver cancer	0.00223	0.00851	CcSEcCtD
Eplerenone—Serum creatinine increased—Epirubicin—liver cancer	0.00217	0.00828	CcSEcCtD
Eplerenone—Urine analysis abnormal—Doxorubicin—liver cancer	0.0021	0.00802	CcSEcCtD
Eplerenone—Pneumonia—Sorafenib—liver cancer	0.00203	0.00775	CcSEcCtD
Eplerenone—Infestation—Sorafenib—liver cancer	0.00202	0.00771	CcSEcCtD
Eplerenone—Infestation NOS—Sorafenib—liver cancer	0.00202	0.00771	CcSEcCtD
Eplerenone—Serum creatinine increased—Doxorubicin—liver cancer	0.00201	0.00766	CcSEcCtD
Eplerenone—Acute coronary syndrome—Sorafenib—liver cancer	0.00199	0.0076	CcSEcCtD
Eplerenone—Renal failure—Sorafenib—liver cancer	0.00199	0.00758	CcSEcCtD
Eplerenone—Neuropathy peripheral—Sorafenib—liver cancer	0.00198	0.00756	CcSEcCtD
Eplerenone—Myocardial infarction—Sorafenib—liver cancer	0.00198	0.00756	CcSEcCtD
Eplerenone—Hepatobiliary disease—Sorafenib—liver cancer	0.00191	0.00729	CcSEcCtD
Eplerenone—Vaginal haemorrhage—Epirubicin—liver cancer	0.00181	0.00688	CcSEcCtD
Eplerenone—Ventricular arrhythmia—Epirubicin—liver cancer	0.00181	0.00688	CcSEcCtD
Eplerenone—Urinary tract disorder—Sorafenib—liver cancer	0.00179	0.00684	CcSEcCtD
Eplerenone—Albuminuria—Epirubicin—liver cancer	0.00179	0.00682	CcSEcCtD
Eplerenone—Connective tissue disorder—Sorafenib—liver cancer	0.00178	0.0068	CcSEcCtD
Eplerenone—Urethral disorder—Sorafenib—liver cancer	0.00178	0.00678	CcSEcCtD
Eplerenone—Tinnitus—Sorafenib—liver cancer	0.00169	0.00645	CcSEcCtD
Eplerenone—Cardiac disorder—Sorafenib—liver cancer	0.00169	0.00642	CcSEcCtD
Eplerenone—Flushing—Sorafenib—liver cancer	0.00169	0.00642	CcSEcCtD
Eplerenone—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00167	0.00637	CcSEcCtD
Eplerenone—Vaginal haemorrhage—Doxorubicin—liver cancer	0.00167	0.00637	CcSEcCtD
Eplerenone—Albuminuria—Doxorubicin—liver cancer	0.00166	0.00631	CcSEcCtD
Eplerenone—Angiopathy—Sorafenib—liver cancer	0.00165	0.00628	CcSEcCtD
Eplerenone—Mediastinal disorder—Sorafenib—liver cancer	0.00164	0.00624	CcSEcCtD
Eplerenone—Mental disorder—Sorafenib—liver cancer	0.00159	0.00606	CcSEcCtD
Eplerenone—Malnutrition—Sorafenib—liver cancer	0.00158	0.00603	CcSEcCtD
Eplerenone—Breast pain—Epirubicin—liver cancer	0.00153	0.00584	CcSEcCtD
Eplerenone—Cardiovascular disorder—Epirubicin—liver cancer	0.00152	0.0058	CcSEcCtD
Eplerenone—Muscle spasms—Sorafenib—liver cancer	0.00152	0.00579	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Epirubicin—liver cancer	0.00147	0.0056	CcSEcCtD
Eplerenone—Anaemia—Sorafenib—liver cancer	0.00146	0.00557	CcSEcCtD
Eplerenone—Angioedema—Sorafenib—liver cancer	0.00144	0.00551	CcSEcCtD
Eplerenone—Hyperuricaemia—Epirubicin—liver cancer	0.00144	0.00549	CcSEcCtD
Eplerenone—Syncope—Sorafenib—liver cancer	0.00142	0.0054	CcSEcCtD
Eplerenone—Breast pain—Doxorubicin—liver cancer	0.00142	0.0054	CcSEcCtD
Eplerenone—Cardiovascular disorder—Doxorubicin—liver cancer	0.00141	0.00536	CcSEcCtD
Eplerenone—Creatinine increased—Epirubicin—liver cancer	0.0014	0.00535	CcSEcCtD
Eplerenone—Loss of consciousness—Sorafenib—liver cancer	0.00139	0.0053	CcSEcCtD
Eplerenone—Cough—Sorafenib—liver cancer	0.00138	0.00526	CcSEcCtD
Eplerenone—Blood uric acid increased—Epirubicin—liver cancer	0.00136	0.00519	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00136	0.00518	CcSEcCtD
Eplerenone—Musculoskeletal pain—Epirubicin—liver cancer	0.00135	0.00516	CcSEcCtD
Eplerenone—Myalgia—Sorafenib—liver cancer	0.00135	0.00513	CcSEcCtD
Eplerenone—Arthralgia—Sorafenib—liver cancer	0.00135	0.00513	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00134	0.00509	CcSEcCtD
Eplerenone—Ventricular tachycardia—Epirubicin—liver cancer	0.00134	0.00509	CcSEcCtD
Eplerenone—Hyperuricaemia—Doxorubicin—liver cancer	0.00133	0.00508	CcSEcCtD
Eplerenone—Hyperkalaemia—Epirubicin—liver cancer	0.00131	0.005	CcSEcCtD
Eplerenone—Creatinine increased—Doxorubicin—liver cancer	0.0013	0.00495	CcSEcCtD
Eplerenone—Influenza like illness—Epirubicin—liver cancer	0.0013	0.00495	CcSEcCtD
Eplerenone—Infection—Sorafenib—liver cancer	0.00128	0.00489	CcSEcCtD
Eplerenone—Shock—Sorafenib—liver cancer	0.00127	0.00484	CcSEcCtD
Eplerenone—Nervous system disorder—Sorafenib—liver cancer	0.00127	0.00482	CcSEcCtD
Eplerenone—Blood urea increased—Epirubicin—liver cancer	0.00126	0.00481	CcSEcCtD
Eplerenone—Blood uric acid increased—Doxorubicin—liver cancer	0.00126	0.0048	CcSEcCtD
Eplerenone—Skin disorder—Sorafenib—liver cancer	0.00125	0.00478	CcSEcCtD
Eplerenone—Fluoxymesterone—ESR1—liver cancer	0.00125	0.271	CrCbGaD
Eplerenone—Musculoskeletal pain—Doxorubicin—liver cancer	0.00125	0.00477	CcSEcCtD
Eplerenone—Ventricular tachycardia—Doxorubicin—liver cancer	0.00124	0.00471	CcSEcCtD
Eplerenone—Hyperkalaemia—Doxorubicin—liver cancer	0.00121	0.00463	CcSEcCtD
Eplerenone—Influenza like illness—Doxorubicin—liver cancer	0.0012	0.00458	CcSEcCtD
Eplerenone—Pulmonary oedema—Epirubicin—liver cancer	0.00119	0.00453	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00118	0.00448	CcSEcCtD
Eplerenone—Blood urea increased—Doxorubicin—liver cancer	0.00117	0.00445	CcSEcCtD
Eplerenone—Dyspnoea—Sorafenib—liver cancer	0.00115	0.00438	CcSEcCtD
Eplerenone—Dyspepsia—Sorafenib—liver cancer	0.00114	0.00433	CcSEcCtD
Eplerenone—Diabetes mellitus—Epirubicin—liver cancer	0.00112	0.00425	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Sorafenib—liver cancer	0.00111	0.00425	CcSEcCtD
Eplerenone—Fatigue—Sorafenib—liver cancer	0.00111	0.00424	CcSEcCtD
Eplerenone—Constipation—Sorafenib—liver cancer	0.0011	0.00421	CcSEcCtD
Eplerenone—Pain—Sorafenib—liver cancer	0.0011	0.00421	CcSEcCtD
Eplerenone—Pulmonary oedema—Doxorubicin—liver cancer	0.0011	0.0042	CcSEcCtD
Eplerenone—Medroxyprogesterone Acetate—ESR1—liver cancer	0.00107	0.232	CrCbGaD
Eplerenone—Gastrointestinal pain—Sorafenib—liver cancer	0.00105	0.00402	CcSEcCtD
Eplerenone—Diabetes mellitus—Doxorubicin—liver cancer	0.00103	0.00393	CcSEcCtD
Eplerenone—Abdominal pain—Sorafenib—liver cancer	0.00102	0.00389	CcSEcCtD
Eplerenone—Body temperature increased—Sorafenib—liver cancer	0.00102	0.00389	CcSEcCtD
Eplerenone—Renal impairment—Epirubicin—liver cancer	0.00102	0.00389	CcSEcCtD
Eplerenone—Hyponatraemia—Epirubicin—liver cancer	0.000974	0.00371	CcSEcCtD
Eplerenone—Renal impairment—Doxorubicin—liver cancer	0.000943	0.00359	CcSEcCtD
Eplerenone—Asthenia—Sorafenib—liver cancer	0.000926	0.00353	CcSEcCtD
Eplerenone—Pruritus—Sorafenib—liver cancer	0.000913	0.00348	CcSEcCtD
Eplerenone—Blood creatinine increased—Epirubicin—liver cancer	0.000909	0.00346	CcSEcCtD
Eplerenone—Dehydration—Epirubicin—liver cancer	0.000902	0.00344	CcSEcCtD
Eplerenone—Hyponatraemia—Doxorubicin—liver cancer	0.000901	0.00344	CcSEcCtD
Eplerenone—Orthostatic hypotension—Epirubicin—liver cancer	0.000886	0.00338	CcSEcCtD
Eplerenone—Hypokalaemia—Epirubicin—liver cancer	0.000883	0.00337	CcSEcCtD
Eplerenone—Diarrhoea—Sorafenib—liver cancer	0.000883	0.00336	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000874	0.00333	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000856	0.00326	CcSEcCtD
Eplerenone—Dizziness—Sorafenib—liver cancer	0.000853	0.00325	CcSEcCtD
Eplerenone—Blood creatinine increased—Doxorubicin—liver cancer	0.000841	0.00321	CcSEcCtD
Eplerenone—Dehydration—Doxorubicin—liver cancer	0.000835	0.00318	CcSEcCtD
Eplerenone—Eosinophilia—Epirubicin—liver cancer	0.00083	0.00316	CcSEcCtD
Eplerenone—Vomiting—Sorafenib—liver cancer	0.00082	0.00313	CcSEcCtD
Eplerenone—Orthostatic hypotension—Doxorubicin—liver cancer	0.00082	0.00312	CcSEcCtD
Eplerenone—Hypokalaemia—Doxorubicin—liver cancer	0.000817	0.00311	CcSEcCtD
Eplerenone—Angina pectoris—Epirubicin—liver cancer	0.000817	0.00311	CcSEcCtD
Eplerenone—Rash—Sorafenib—liver cancer	0.000813	0.0031	CcSEcCtD
Eplerenone—Dermatitis—Sorafenib—liver cancer	0.000813	0.0031	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000808	0.00308	CcSEcCtD
Eplerenone—Headache—Sorafenib—liver cancer	0.000808	0.00308	CcSEcCtD
Eplerenone—Bronchitis—Epirubicin—liver cancer	0.000806	0.00307	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000792	0.00302	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Epirubicin—liver cancer	0.000779	0.00297	CcSEcCtD
Eplerenone—Eosinophilia—Doxorubicin—liver cancer	0.000768	0.00293	CcSEcCtD
Eplerenone—Nausea—Sorafenib—liver cancer	0.000766	0.00292	CcSEcCtD
Eplerenone—Hyperglycaemia—Epirubicin—liver cancer	0.000756	0.00288	CcSEcCtD
Eplerenone—Angina pectoris—Doxorubicin—liver cancer	0.000756	0.00288	CcSEcCtD
Eplerenone—Pneumonia—Epirubicin—liver cancer	0.000752	0.00287	CcSEcCtD
Eplerenone—Infestation NOS—Epirubicin—liver cancer	0.000748	0.00285	CcSEcCtD
Eplerenone—Infestation—Epirubicin—liver cancer	0.000748	0.00285	CcSEcCtD
Eplerenone—Bronchitis—Doxorubicin—liver cancer	0.000746	0.00284	CcSEcCtD
Eplerenone—Renal failure—Epirubicin—liver cancer	0.000735	0.0028	CcSEcCtD
Eplerenone—Neuropathy peripheral—Epirubicin—liver cancer	0.000733	0.00279	CcSEcCtD
Eplerenone—Urinary tract infection—Epirubicin—liver cancer	0.000727	0.00277	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000721	0.00275	CcSEcCtD
Eplerenone—Haematuria—Epirubicin—liver cancer	0.000713	0.00272	CcSEcCtD
Eplerenone—Hepatobiliary disease—Epirubicin—liver cancer	0.000707	0.00269	CcSEcCtD
Eplerenone—Hyperglycaemia—Doxorubicin—liver cancer	0.0007	0.00267	CcSEcCtD
Eplerenone—Pneumonia—Doxorubicin—liver cancer	0.000696	0.00265	CcSEcCtD
Eplerenone—Infestation NOS—Doxorubicin—liver cancer	0.000692	0.00264	CcSEcCtD
Eplerenone—Infestation—Doxorubicin—liver cancer	0.000692	0.00264	CcSEcCtD
Eplerenone—Renal failure—Doxorubicin—liver cancer	0.00068	0.00259	CcSEcCtD
Eplerenone—Neuropathy peripheral—Doxorubicin—liver cancer	0.000678	0.00258	CcSEcCtD
Eplerenone—Urinary tract infection—Doxorubicin—liver cancer	0.000672	0.00256	CcSEcCtD
Eplerenone—Hypoaesthesia—Epirubicin—liver cancer	0.000668	0.00255	CcSEcCtD
Eplerenone—Pharyngitis—Epirubicin—liver cancer	0.000666	0.00254	CcSEcCtD
Eplerenone—Urinary tract disorder—Epirubicin—liver cancer	0.000663	0.00253	CcSEcCtD
Eplerenone—Oedema peripheral—Epirubicin—liver cancer	0.000661	0.00252	CcSEcCtD
Eplerenone—Haematuria—Doxorubicin—liver cancer	0.00066	0.00251	CcSEcCtD
Eplerenone—Connective tissue disorder—Epirubicin—liver cancer	0.000659	0.00251	CcSEcCtD
Eplerenone—Urethral disorder—Epirubicin—liver cancer	0.000658	0.00251	CcSEcCtD
Eplerenone—Hepatobiliary disease—Doxorubicin—liver cancer	0.000654	0.00249	CcSEcCtD
Eplerenone—Tinnitus—Epirubicin—liver cancer	0.000626	0.00238	CcSEcCtD
Eplerenone—Flushing—Epirubicin—liver cancer	0.000623	0.00237	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—liver cancer	0.000623	0.00237	CcSEcCtD
Eplerenone—Progesterone—ESR1—liver cancer	0.000621	0.134	CrCbGaD
Eplerenone—Hypoaesthesia—Doxorubicin—liver cancer	0.000618	0.00235	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—liver cancer	0.000616	0.00235	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—liver cancer	0.000613	0.00234	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—liver cancer	0.000612	0.00233	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—liver cancer	0.00061	0.00233	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—liver cancer	0.000609	0.00232	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—liver cancer	0.000609	0.00232	CcSEcCtD
Eplerenone—Mediastinal disorder—Epirubicin—liver cancer	0.000605	0.00231	CcSEcCtD
Eplerenone—Mental disorder—Epirubicin—liver cancer	0.000588	0.00224	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—liver cancer	0.000584	0.00223	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—liver cancer	0.000579	0.00221	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—liver cancer	0.000576	0.0022	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—liver cancer	0.000576	0.0022	CcSEcCtD
Eplerenone—Flatulence—Epirubicin—liver cancer	0.000576	0.00219	CcSEcCtD
Eplerenone—Back pain—Epirubicin—liver cancer	0.000565	0.00215	CcSEcCtD
Eplerenone—Angiopathy—Doxorubicin—liver cancer	0.000563	0.00215	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—liver cancer	0.000562	0.00214	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—liver cancer	0.00056	0.00213	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTA4—liver cancer	0.000546	0.00336	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—HNF4A—liver cancer	0.000545	0.00336	CbGpPWpGaD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000545	0.00336	CbGpPWpGaD
Eplerenone—Mental disorder—Doxorubicin—liver cancer	0.000544	0.00207	CcSEcCtD
Eplerenone—Ill-defined disorder—Epirubicin—liver cancer	0.000542	0.00207	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—liver cancer	0.000541	0.00206	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—liver cancer	0.00054	0.00206	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTA4—liver cancer	0.000539	0.00332	CbGpPWpGaD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000534	0.00329	CbGpPWpGaD
Eplerenone—Flatulence—Doxorubicin—liver cancer	0.000533	0.00203	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTA2—liver cancer	0.000532	0.00328	CbGpPWpGaD
Eplerenone—Malaise—Epirubicin—liver cancer	0.000527	0.00201	CcSEcCtD
Eplerenone—Syncope—Epirubicin—liver cancer	0.000524	0.002	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—liver cancer	0.000523	0.00199	CcSEcCtD
Eplerenone—Muscle spasms—Doxorubicin—liver cancer	0.00052	0.00198	CcSEcCtD
Eplerenone—Loss of consciousness—Epirubicin—liver cancer	0.000513	0.00196	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GSTA1—liver cancer	0.000513	0.00316	CbGpPWpGaD
Eplerenone—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000513	0.00316	CbGpPWpGaD
Eplerenone—Cough—Epirubicin—liver cancer	0.00051	0.00194	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—NAT2—liver cancer	0.000508	0.00313	CbGpPWpGaD
Eplerenone—Ill-defined disorder—Doxorubicin—liver cancer	0.000502	0.00191	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—NAT2—liver cancer	0.000501	0.00309	CbGpPWpGaD
Eplerenone—Anaemia—Doxorubicin—liver cancer	0.0005	0.0019	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—liver cancer	0.000497	0.0019	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—liver cancer	0.000497	0.0019	CcSEcCtD
Eplerenone—Chest pain—Epirubicin—liver cancer	0.000497	0.0019	CcSEcCtD
Eplerenone—Progesterone—CYP1A1—liver cancer	0.000496	0.107	CrCbGaD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000494	0.00188	CcSEcCtD
Eplerenone—Discomfort—Epirubicin—liver cancer	0.000491	0.00187	CcSEcCtD
Eplerenone—Malaise—Doxorubicin—liver cancer	0.000487	0.00186	CcSEcCtD
Eplerenone—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000486	0.00299	CbGpPWpGaD
Eplerenone—Syncope—Doxorubicin—liver cancer	0.000485	0.00185	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—EXOSC2—liver cancer	0.000484	0.00298	CbGpPWpGaD
Eplerenone—Loss of consciousness—Doxorubicin—liver cancer	0.000475	0.00181	CcSEcCtD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000474	0.00292	CbGpPWpGaD
Eplerenone—Infection—Epirubicin—liver cancer	0.000474	0.00181	CcSEcCtD
Eplerenone—Cough—Doxorubicin—liver cancer	0.000472	0.0018	CcSEcCtD
Eplerenone—Shock—Epirubicin—liver cancer	0.000469	0.00179	CcSEcCtD
Eplerenone—Testosterone—CYP1A1—liver cancer	0.000469	0.101	CrCbGaD
Eplerenone—Nervous system disorder—Epirubicin—liver cancer	0.000468	0.00178	CcSEcCtD
Eplerenone—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000465	0.00287	CbGpPWpGaD
Eplerenone—Skin disorder—Epirubicin—liver cancer	0.000463	0.00177	CcSEcCtD
Eplerenone—Hyperhidrosis—Epirubicin—liver cancer	0.000461	0.00176	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—liver cancer	0.00046	0.00175	CcSEcCtD
Eplerenone—Myalgia—Doxorubicin—liver cancer	0.00046	0.00175	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—liver cancer	0.00046	0.00175	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000457	0.00174	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—liver cancer	0.000455	0.00173	CcSEcCtD
Eplerenone—Methyltestosterone—ALB—liver cancer	0.00045	0.0974	CrCbGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00045	0.00277	CbGpPWpGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000447	0.00276	CbGpPWpGaD
Eplerenone—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000447	0.00275	CbGpPWpGaD
Eplerenone—Hypotension—Epirubicin—liver cancer	0.000446	0.0017	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—NR1H4—liver cancer	0.000439	0.00271	CbGpPWpGaD
Eplerenone—Infection—Doxorubicin—liver cancer	0.000438	0.00167	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000434	0.00166	CcSEcCtD
Eplerenone—Shock—Doxorubicin—liver cancer	0.000434	0.00165	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—liver cancer	0.000433	0.00165	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTA3—liver cancer	0.000432	0.00266	CbGpPWpGaD
Eplerenone—Insomnia—Epirubicin—liver cancer	0.000431	0.00164	CcSEcCtD
Eplerenone—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00043	0.00265	CbGpPWpGaD
Eplerenone—Skin disorder—Doxorubicin—liver cancer	0.000429	0.00163	CcSEcCtD
Eplerenone—Hyperhidrosis—Doxorubicin—liver cancer	0.000426	0.00163	CcSEcCtD
Eplerenone—CYP3A7—Metapathway biotransformation—GPX3—liver cancer	0.000426	0.00262	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTA3—liver cancer	0.000426	0.00262	CbGpPWpGaD
Eplerenone—Dyspnoea—Epirubicin—liver cancer	0.000425	0.00162	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00042	0.00259	CbGpPWpGaD
Eplerenone—Dyspepsia—Epirubicin—liver cancer	0.00042	0.0016	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—UGDH—liver cancer	0.000419	0.00258	CbGpPWpGaD
Eplerenone—Hypotension—Doxorubicin—liver cancer	0.000412	0.00157	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000412	0.00157	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—liver cancer	0.000411	0.00157	CcSEcCtD
Eplerenone—Pain—Epirubicin—liver cancer	0.000408	0.00155	CcSEcCtD
Eplerenone—Constipation—Epirubicin—liver cancer	0.000408	0.00155	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000407	0.00251	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—HPGDS—liver cancer	0.000406	0.0025	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000402	0.00153	CcSEcCtD
Eplerenone—Insomnia—Doxorubicin—liver cancer	0.000399	0.00152	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000399	0.00246	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTA4—liver cancer	0.000395	0.00243	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—EPT1—liver cancer	0.000394	0.00243	CbGpPWpGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000394	0.00243	CbGpPWpGaD
Eplerenone—Dyspnoea—Doxorubicin—liver cancer	0.000393	0.0015	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—liver cancer	0.000393	0.0015	CcSEcCtD
Eplerenone—Gastrointestinal pain—Epirubicin—liver cancer	0.00039	0.00149	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTA4—liver cancer	0.000389	0.0024	CbGpPWpGaD
Eplerenone—Dyspepsia—Doxorubicin—liver cancer	0.000388	0.00148	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—NR1H4—liver cancer	0.000385	0.00237	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTA2—liver cancer	0.000385	0.00237	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000384	0.00237	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000381	0.00145	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—liver cancer	0.00038	0.00145	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—NR1I3—liver cancer	0.000379	0.00233	CbGpPWpGaD
Eplerenone—Pain—Doxorubicin—liver cancer	0.000377	0.00144	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—liver cancer	0.000377	0.00144	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—liver cancer	0.000377	0.00144	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—liver cancer	0.000377	0.00144	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—TAT—liver cancer	0.000374	0.0023	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTA1—liver cancer	0.000371	0.00229	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000367	0.00226	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—NAT2—liver cancer	0.000367	0.00226	CbGpPWpGaD
Eplerenone—Feeling abnormal—Doxorubicin—liver cancer	0.000364	0.00139	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—NAT2—liver cancer	0.000362	0.00223	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000361	0.00138	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000349	0.00215	CbGpPWpGaD
Eplerenone—Body temperature increased—Doxorubicin—liver cancer	0.000349	0.00133	CcSEcCtD
Eplerenone—Abdominal pain—Doxorubicin—liver cancer	0.000349	0.00133	CcSEcCtD
Eplerenone—Asthenia—Epirubicin—liver cancer	0.000342	0.0013	CcSEcCtD
Eplerenone—Pruritus—Epirubicin—liver cancer	0.000337	0.00129	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—CYP2E1—liver cancer	0.000331	0.00204	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP2E1—liver cancer	0.000326	0.00201	CbGpPWpGaD
Eplerenone—Diarrhoea—Epirubicin—liver cancer	0.000326	0.00124	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000323	0.00199	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000319	0.00197	CbGpPWpGaD
Eplerenone—Asthenia—Doxorubicin—liver cancer	0.000317	0.00121	CcSEcCtD
Eplerenone—Dizziness—Epirubicin—liver cancer	0.000315	0.0012	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—liver cancer	0.000312	0.00119	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GPX3—liver cancer	0.000308	0.0019	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GGT1—liver cancer	0.000304	0.00187	CbGpPWpGaD
Eplerenone—Vomiting—Epirubicin—liver cancer	0.000303	0.00116	CcSEcCtD
Eplerenone—Diarrhoea—Doxorubicin—liver cancer	0.000302	0.00115	CcSEcCtD
Eplerenone—Rash—Epirubicin—liver cancer	0.000301	0.00115	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—liver cancer	0.0003	0.00114	CcSEcCtD
Eplerenone—Headache—Epirubicin—liver cancer	0.000299	0.00114	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—HPGDS—liver cancer	0.000293	0.00181	CbGpPWpGaD
Eplerenone—Dizziness—Doxorubicin—liver cancer	0.000292	0.00111	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—PPARA—liver cancer	0.000286	0.00176	CbGpPWpGaD
Eplerenone—Nausea—Epirubicin—liver cancer	0.000283	0.00108	CcSEcCtD
Eplerenone—Vomiting—Doxorubicin—liver cancer	0.000281	0.00107	CcSEcCtD
Eplerenone—Rash—Doxorubicin—liver cancer	0.000278	0.00106	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—liver cancer	0.000278	0.00106	CcSEcCtD
Eplerenone—Headache—Doxorubicin—liver cancer	0.000276	0.00105	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000275	0.00169	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTP1—liver cancer	0.000273	0.00168	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTP1—liver cancer	0.000269	0.00166	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000267	0.00165	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—HNF4A—liver cancer	0.000263	0.00162	CbGpPWpGaD
Eplerenone—Nausea—Doxorubicin—liver cancer	0.000262	0.000999	CcSEcCtD
Eplerenone—Testosterone—ALB—liver cancer	0.000261	0.0565	CrCbGaD
Eplerenone—NR3C2—Generic Transcription Pathway—ESR1—liver cancer	0.000259	0.0016	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000258	0.00159	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000255	0.00157	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CPT1B—liver cancer	0.000254	0.00157	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GLUL—liver cancer	0.000254	0.00157	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GSTM1—liver cancer	0.000251	0.00155	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—GSTM1—liver cancer	0.000247	0.00152	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NR1H4—liver cancer	0.000245	0.00151	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTA3—liver cancer	0.000241	0.00148	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP2E1—liver cancer	0.000239	0.00147	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP1A1—liver cancer	0.000238	0.00146	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—PPARG—liver cancer	0.000237	0.00146	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP2E1—liver cancer	0.000236	0.00145	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP1A1—liver cancer	0.000234	0.00144	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PSMA4—liver cancer	0.000229	0.00141	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PSMD10—liver cancer	0.000229	0.00141	CbGpPWpGaD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000229	0.00141	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000221	0.00136	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTA4—liver cancer	0.00022	0.00136	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GGT1—liver cancer	0.00022	0.00135	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000215	0.00133	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTA2—liver cancer	0.000215	0.00132	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—SERPINE1—liver cancer	0.000213	0.00131	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000209	0.00129	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTA1—liver cancer	0.000207	0.00128	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NAT2—liver cancer	0.000205	0.00126	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000204	0.00126	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000201	0.00124	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000198	0.00122	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTP1—liver cancer	0.000197	0.00122	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000197	0.00121	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALDOB—liver cancer	0.000196	0.00121	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTP1—liver cancer	0.000195	0.0012	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CRABP1—liver cancer	0.000187	0.00115	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000185	0.00114	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000184	0.00113	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000183	0.00113	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GSTM1—liver cancer	0.000181	0.00112	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000181	0.00112	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000179	0.0011	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTM1—liver cancer	0.000179	0.0011	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—UGDH—liver cancer	0.000178	0.0011	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000173	0.00106	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP1A1—liver cancer	0.000172	0.00106	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000171	0.00105	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP1A1—liver cancer	0.000169	0.00104	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000169	0.00104	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000168	0.00104	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—EPT1—liver cancer	0.000167	0.00103	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—HPGDS—liver cancer	0.000164	0.00101	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000163	0.001	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TAT—liver cancer	0.000158	0.000976	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—H2AFX—liver cancer	0.000155	0.000955	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00015	0.000927	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000148	0.000913	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000146	0.000902	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PSMA4—liver cancer	0.000146	0.000899	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PSMD10—liver cancer	0.000146	0.000899	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000143	0.000882	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GOT2—liver cancer	0.000142	0.000874	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PPARA—liver cancer	0.000138	0.00085	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000136	0.00084	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—MYC—liver cancer	0.000135	0.000832	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP2E1—liver cancer	0.000133	0.000822	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000129	0.000796	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—UGDH—liver cancer	0.000129	0.000792	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MAPK14—liver cancer	0.000127	0.000785	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—ESR1—liver cancer	0.000125	0.00077	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYCS—liver cancer	0.000125	0.000769	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GGT1—liver cancer	0.000122	0.000755	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GOT1—liver cancer	0.000122	0.000755	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—EPT1—liver cancer	0.000121	0.000745	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TAT—liver cancer	0.000115	0.000706	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PPARG—liver cancer	0.000114	0.000702	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000111	0.000685	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTP1—liver cancer	0.00011	0.000678	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.00011	0.000676	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—HMOX1—liver cancer	0.000109	0.000669	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CPT1B—liver cancer	0.000108	0.000664	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GLUL—liver cancer	0.000108	0.000664	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NR1H4—liver cancer	0.000104	0.00064	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—SERPINE1—liver cancer	0.000103	0.000633	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTA3—liver cancer	0.000102	0.000629	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000102	0.000629	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTM1—liver cancer	0.000101	0.000623	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP1A1—liver cancer	9.58e-05	0.000591	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTA4—liver cancer	9.34e-05	0.000575	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTP1—liver cancer	9.17e-05	0.000565	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTA2—liver cancer	9.1e-05	0.000561	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	9.04e-05	0.000557	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—MTHFR—liver cancer	8.94e-05	0.000551	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTA1—liver cancer	8.78e-05	0.000541	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPARA—liver cancer	8.77e-05	0.00054	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NAT2—liver cancer	8.68e-05	0.000535	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTM1—liver cancer	8.43e-05	0.000519	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALDOB—liver cancer	8.32e-05	0.000513	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	8.31e-05	0.000512	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	7.99e-05	0.000492	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CRABP1—liver cancer	7.94e-05	0.000489	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	7.88e-05	0.000485	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.87e-05	0.000485	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CPT1B—liver cancer	7.79e-05	0.00048	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GLUL—liver cancer	7.79e-05	0.00048	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CG—liver cancer	7.51e-05	0.000463	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NR1H4—liver cancer	7.51e-05	0.000463	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA3—liver cancer	7.38e-05	0.000455	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPARG—liver cancer	7.25e-05	0.000447	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HPGDS—liver cancer	6.94e-05	0.000428	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA4—liver cancer	6.75e-05	0.000416	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CD—liver cancer	6.6e-05	0.000407	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA2—liver cancer	6.58e-05	0.000405	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALB—liver cancer	6.52e-05	0.000401	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MYC—liver cancer	6.5e-05	0.0004	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTA1—liver cancer	6.35e-05	0.000391	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NAT2—liver cancer	6.28e-05	0.000387	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PSMD10—liver cancer	6.19e-05	0.000381	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PSMA4—liver cancer	6.19e-05	0.000381	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GOT2—liver cancer	6.02e-05	0.000371	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALDOB—liver cancer	6.02e-05	0.000371	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—UGDH—liver cancer	5.97e-05	0.000368	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CB—liver cancer	5.75e-05	0.000355	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CRABP1—liver cancer	5.74e-05	0.000354	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2E1—liver cancer	5.66e-05	0.000349	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—EPT1—liver cancer	5.62e-05	0.000346	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TAT—liver cancer	5.32e-05	0.000328	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYCS—liver cancer	5.29e-05	0.000326	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GGT1—liver cancer	5.19e-05	0.00032	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GOT1—liver cancer	5.19e-05	0.00032	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HPGDS—liver cancer	5.02e-05	0.000309	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—liver cancer	4.67e-05	0.000288	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HMOX1—liver cancer	4.6e-05	0.000284	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—AKT1—liver cancer	4.51e-05	0.000278	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PSMD10—liver cancer	4.47e-05	0.000276	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PSMA4—liver cancer	4.47e-05	0.000276	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GOT2—liver cancer	4.35e-05	0.000268	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTM1—liver cancer	4.29e-05	0.000264	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2E1—liver cancer	4.09e-05	0.000252	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP1A1—liver cancer	4.06e-05	0.00025	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYCS—liver cancer	3.83e-05	0.000236	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MTHFR—liver cancer	3.79e-05	0.000234	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GOT1—liver cancer	3.75e-05	0.000231	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GGT1—liver cancer	3.75e-05	0.000231	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPARA—liver cancer	3.72e-05	0.000229	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GLUL—liver cancer	3.62e-05	0.000223	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CPT1B—liver cancer	3.62e-05	0.000223	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CA—liver cancer	3.51e-05	0.000216	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NR1H4—liver cancer	3.49e-05	0.000215	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA3—liver cancer	3.43e-05	0.000211	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—liver cancer	3.37e-05	0.000208	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HMOX1—liver cancer	3.33e-05	0.000205	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CG—liver cancer	3.18e-05	0.000196	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA4—liver cancer	3.14e-05	0.000193	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTM1—liver cancer	3.1e-05	0.000191	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPARG—liver cancer	3.07e-05	0.000189	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA2—liver cancer	3.06e-05	0.000188	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTA1—liver cancer	2.95e-05	0.000182	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP1A1—liver cancer	2.94e-05	0.000181	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NAT2—liver cancer	2.92e-05	0.00018	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKT1—liver cancer	2.86e-05	0.000177	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CD—liver cancer	2.8e-05	0.000172	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALDOB—liver cancer	2.8e-05	0.000172	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALB—liver cancer	2.76e-05	0.00017	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MTHFR—liver cancer	2.74e-05	0.000169	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPARA—liver cancer	2.69e-05	0.000166	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CRABP1—liver cancer	2.67e-05	0.000164	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CB—liver cancer	2.44e-05	0.00015	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HPGDS—liver cancer	2.33e-05	0.000144	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CG—liver cancer	2.3e-05	0.000142	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPARG—liver cancer	2.22e-05	0.000137	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PSMD10—liver cancer	2.08e-05	0.000128	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PSMA4—liver cancer	2.08e-05	0.000128	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CD—liver cancer	2.02e-05	0.000125	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GOT2—liver cancer	2.02e-05	0.000125	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALB—liver cancer	2e-05	0.000123	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2E1—liver cancer	1.9e-05	0.000117	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYCS—liver cancer	1.78e-05	0.00011	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CB—liver cancer	1.76e-05	0.000109	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GGT1—liver cancer	1.75e-05	0.000108	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GOT1—liver cancer	1.75e-05	0.000108	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—liver cancer	1.57e-05	9.66e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HMOX1—liver cancer	1.55e-05	9.53e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CA—liver cancer	1.49e-05	9.16e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTM1—liver cancer	1.44e-05	8.88e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP1A1—liver cancer	1.37e-05	8.42e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTHFR—liver cancer	1.27e-05	7.85e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPARA—liver cancer	1.25e-05	7.7e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKT1—liver cancer	1.21e-05	7.49e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CA—liver cancer	1.08e-05	6.62e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CG—liver cancer	1.07e-05	6.59e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPARG—liver cancer	1.03e-05	6.36e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CD—liver cancer	9.41e-06	5.8e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALB—liver cancer	9.29e-06	5.72e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKT1—liver cancer	8.78e-06	5.41e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CB—liver cancer	8.2e-06	5.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CA—liver cancer	5e-06	3.08e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKT1—liver cancer	4.08e-06	2.52e-05	CbGpPWpGaD
